Logo image of JAX

J. Alexander's Holdings Inc C (JAX) Stock Fundamental Analysis

NYSE:JAX - New York Stock Exchange, Inc. -

14  +0.02 (+0.14%)

After market: 14 0 (0%)

Fundamental Rating

1

JAX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 136 industry peers in the Hotels, Restaurants & Leisure industry. JAX has a bad profitability rating. Also its financial health evaluation is rather negative. JAX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

JAX had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 3.15%
ROE 6.69%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 2.56%
PM (TTM) 3.48%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

JAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

JAX has an Altman-Z score of 2.00. This is not the best score and indicates that JAX is in the grey zone with still only limited risk for bankruptcy at the moment.
JAX has a Debt/Equity ratio of 0.77. This is a neutral value indicating JAX is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 2
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

JAX has a Current Ratio of 1.20. This is a normal value and indicates that JAX is financially healthy and should not expect problems in meeting its short term obligations.
JAX has a Quick Ratio of 1.10. This is a normal value and indicates that JAX is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.1

More info and screens

3

3. Growth

3.1 Past

The earnings per share for JAX have decreased strongly by -17.28% in the last year.
Measured over the past years, JAX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.12% on average per year.
Looking at the last year, JAX shows a quite strong growth in Revenue. The Revenue has grown by 9.47% in the last year.
The Revenue has been decreasing by -3.39% on average over the past years.
EPS 1Y (TTM)-17.28%
EPS 3Y16.47%
EPS 5Y12.12%
EPS Q2Q%-21.05%
Revenue 1Y (TTM)9.47%
Revenue growth 3Y-7.71%
Revenue growth 5Y-3.39%
Sales Q2Q%146.72%

3.2 Future

Based on estimates for the next years, JAX will show a small growth in Earnings Per Share. The EPS will grow by 5.40% on average per year.
JAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.87% yearly.
EPS Next Y11.1%
EPS Next 2Y5.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.2%
Revenue Next 2Y1.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JAX Yearly Revenue VS EstimatesJAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M
JAX Yearly EPS VS EstimatesJAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.90 indicates a rather expensive valuation of JAX.
JAX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.95 indicates a correct valuation of JAX.
When comparing the Price/Forward Earnings ratio of JAX to the average of the S&P500 Index (20.42), we can say JAX is valued slightly cheaper.
Industry RankSector Rank
PE 20.9
Fwd PE 15.95
JAX Price Earnings VS Forward Price EarningsJAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.79
JAX Per share dataJAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.88
PEG (5Y)1.72
EPS Next 2Y5.4%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

JAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

J. Alexander's Holdings Inc C

NYSE:JAX (9/29/2021, 8:04:00 PM)

After market: 14 0 (0%)

14

+0.02 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.55%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner Change0%
Market Cap211.12M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.9
Fwd PE 15.95
P/S 0.94
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB N/A
EV/EBITDA 15.79
EPS(TTM)0.67
EY4.79%
EPS(NY)0.88
Fwd EY6.27%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.87
BVpS7.73
TBVpSN/A
PEG (NY)1.88
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 3.15%
ROE 6.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 2.56%
PM (TTM) 3.48%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 1.1
Altman-Z 2
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.28%
EPS 3Y16.47%
EPS 5Y12.12%
EPS Q2Q%-21.05%
EPS Next Y11.1%
EPS Next 2Y5.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.47%
Revenue growth 3Y-7.71%
Revenue growth 5Y-3.39%
Sales Q2Q%146.72%
Revenue Next Year0.2%
Revenue Next 2Y1.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A